657 related articles for article (PubMed ID: 28438638)
1. Adenosine A2A receptor modulates neuroimmune function through Th17/retinoid-related orphan receptor gamma t (RORγt) signaling in a BTBR T
Ansari MA; Nadeem A; Attia SM; Bakheet SA; Raish M; Ahmad SF
Cell Signal; 2017 Aug; 36():14-24. PubMed ID: 28438638
[TBL] [Abstract][Full Text] [Related]
2. Activation of adenosine A2A receptor signaling regulates the expression of cytokines associated with immunologic dysfunction in BTBR T
Ansari MA; Attia SM; Nadeem A; Bakheet SA; Raish M; Khan TH; Al-Shabanah OA; Ahmad SF
Mol Cell Neurosci; 2017 Jul; 82():76-87. PubMed ID: 28465254
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):184-191. PubMed ID: 28668513
[TBL] [Abstract][Full Text] [Related]
4. Adenosine A2A receptor signaling affects IL-21/IL-22 cytokines and GATA3/T-bet transcription factor expression in CD4
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Almutairi MM; Attia SM
J Neuroimmunol; 2017 Oct; 311():59-67. PubMed ID: 28807491
[TBL] [Abstract][Full Text] [Related]
5. The adenosine A
Amodeo DA; Cuevas L; Dunn JT; Sweeney JA; Ragozzino ME
Autism Res; 2018 Feb; 11(2):223-233. PubMed ID: 29193861
[TBL] [Abstract][Full Text] [Related]
6. S3I-201, a selective Stat3 inhibitor, restores neuroimmune function through upregulation of Treg signaling in autistic BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Khan MR; Alsaad AMS; Attia SM
Cell Signal; 2018 Dec; 52():127-136. PubMed ID: 30213685
[TBL] [Abstract][Full Text] [Related]
7. DAPTA, a C-C chemokine receptor 5 (CCR5) antagonist attenuates immune aberrations by downregulating Th9/Th17 immune responses in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alotaibi MR; Alasmari AF; Alshammari MA; Al-Mazroua HA; Attia SM
Eur J Pharmacol; 2019 Mar; 846():100-108. PubMed ID: 30658114
[TBL] [Abstract][Full Text] [Related]
8. The histamine-4 receptor antagonist JNJ7777120 prevents immune abnormalities by inhibiting RORγt/T-bet transcription factor signaling pathways in BTBR T
Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Al-Mazroua HA; Khan MR; Alasmari AF; Alanazi WA; As Sobeai HM; Attia SM
Mol Immunol; 2019 Oct; 114():561-570. PubMed ID: 31522074
[TBL] [Abstract][Full Text] [Related]
9. Protection by tyrosine kinase inhibitor, tyrphostin AG126, through the suppression of IL-17A, RORγt, and T-bet signaling, in the BTBR mouse model of autism.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Attia SM
Brain Res Bull; 2018 Sep; 142():328-337. PubMed ID: 30172736
[TBL] [Abstract][Full Text] [Related]
10. Lead (Pb) exposure exacerbates behavioral and immune abnormalities by upregulating Th17 and NF-κB-related signaling in BTBR T
Almutairi MM; Nadeem A; Ansari MA; Bakheet SA; Attia SM; Albekairi TH; Alhosaini K; Algahtani M; Alsaad AMS; Al-Mazroua HA; Ahmad SF
Neurotoxicology; 2022 Jul; 91():340-348. PubMed ID: 35760230
[TBL] [Abstract][Full Text] [Related]
11. The PPARδ agonist GW0742 restores neuroimmune function by regulating Tim-3 and Th17/Treg-related signaling in the BTBR autistic mouse model.
Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Alshammari MA; Attia SM
Neurochem Int; 2018 Nov; 120():251-261. PubMed ID: 30227151
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol Ameliorates Dysregulation of Th1, Th2, Th17, and T Regulatory Cell-Related Transcription Factor Signaling in a BTBR T + tf/J Mouse Model of Autism.
Bakheet SA; Alzahrani MZ; Ansari MA; Nadeem A; Zoheir KMA; Attia SM; Al-Ayadhi LY; Ahmad SF
Mol Neurobiol; 2017 Sep; 54(7):5201-5212. PubMed ID: 27578011
[TBL] [Abstract][Full Text] [Related]
13. The Stat3 inhibitor, S3I-201, downregulates lymphocyte activation markers, chemokine receptors, and inflammatory cytokines in the BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alanazi AZ; Alsanea S; As Sobeai HM; Almutairi MM; Mahmood HM; Attia SM
Brain Res Bull; 2019 Oct; 152():27-34. PubMed ID: 31299319
[TBL] [Abstract][Full Text] [Related]
14. 5-aminoisoquinolinone attenuates social behavior deficits and immune abnormalities in the BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alqahtani F; Alhoshani AR; Alasmari F; Alsaleh NB; Attia SM
Pharmacol Biochem Behav; 2020 Feb; 189():172859. PubMed ID: 31982447
[TBL] [Abstract][Full Text] [Related]
15. Immune Alterations in CD8
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Mohammad R; Attia SM
Mol Neurobiol; 2018 Mar; 55(3):2603-2616. PubMed ID: 28421534
[TBL] [Abstract][Full Text] [Related]
16. Cadmium Exposure Is Associated with Behavioral Deficits and Neuroimmune Dysfunction in BTBR T
Alanazi MM; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Aldossari AA; Almutairi MM; Albekairi TH; Hussein MH; Al-Hamamah MA; Ahmad SF
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047547
[TBL] [Abstract][Full Text] [Related]
17. CXCR2 antagonist SB332235 mitigates deficits in social behavior and dysregulation of Th1/Th22 and T regulatory cell-related transcription factor signaling in male BTBR T
Albekairi NA; Nadeem A; Ansari MA; Attia SM; Bakheet SA; Alanazi MM; Alhamed AS; Albekairi TH; Al-Mazroua HA; Ibrahim KE; Ahmad SF
Pharmacol Biochem Behav; 2022 Jun; 217():173408. PubMed ID: 35644272
[TBL] [Abstract][Full Text] [Related]
18. Development, phenotypes of immune cells in BTBR T
Uddin MN; Yao Y; Manley K; Lawrence DA
Cell Immunol; 2020 Dec; 358():104223. PubMed ID: 33137646
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol attenuates pro-inflammatory cytokines and activation of JAK1-STAT3 in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alzahrani MZ; Alshammari MA; Alanazi WA; Alasmari AF; Attia SM
Eur J Pharmacol; 2018 Jun; 829():70-78. PubMed ID: 29654783
[TBL] [Abstract][Full Text] [Related]
20. Methylmercury chloride exposure exacerbates existing neurobehavioral and immune dysfunctions in the BTBR T
Al-Mazroua HA; Nadeem A; Ansari MA; Attia SM; Albekairi TH; Bakheet SA; Alobaidi AF; Alhosaini K; Alqarni SA; Ibrahim KE; Alsaad AMS; Ahmad SF
Immunol Lett; 2022 Apr; 244():19-27. PubMed ID: 35259423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
